In the combined analysis of all 364 patients, CRP ≥0.2 mg/dL (HR 3.87; 95%CI 1.65–9.07; p = 0.002), metastases (HR 2.80; 1.49–5.25; p = 0.001), tumor size ≥3 cm (HR 1.83; 95%CI 1.05–3.16; p = 0.034), and age (HR 1.56 per 10 years; 95%CI 1.24–1.97; p < 0.001) remained significant factors for OS. Here, CRP is linked to neoplasm.